dpp-4 inhibitors vs. glp-1 agonist analogues and in type 2 diabetes therapy: from structural biology to clinics DPP-4 inhibitors and GLP-1RAs: cardiovascular
Description
Moreover, independent blood pressure reduction and plasma lipid modulation further contribute to cardiovascular protection [58,59]
However, when blood sugar is high too often, we can develop insulin resistance , leaving higher sugar levels in the bloodstream
doi: 10.1016/j.obpill.2023.100071
[DOI] [PMC free article] [PubMed] [Google Scholar] 9.Skajaa N, et al
Med Care 61(8):528535 Reinhardt UE (2006) The pricing Of U.S
Its better to switch as infrequently as possible to avoid confusion around dosing differences between formulas, Watson says
